Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
paroxysmal nocturnal hemoglobinuria
Pharma
AZ's rare disease rising star Ultomiris snags 3rd FDA nod
The FDA has approved AstraZeneca's Ultomiris to treat generalized myasthenia gravis, an autoimmune neuromuscular disorder.
Kevin Dunleavy
Apr 28, 2022 9:15am
Lilly-Innovent, Biogen-Eisai, FDA and more—Fierce Pharma Asia
Feb 11, 2022 6:22am
NICE recommends Sobi's rare disease drug Aspaveli
Dec 9, 2021 9:04am
Even during pandemic, FDA approvals remain on a rapid pace
Jul 6, 2021 11:27am
NICE gives a second nod to Alexion's pricey Ultomiris
May 20, 2021 7:50am
Apellis gets its shot at Alexion’s Soliris with new PNH approval
May 14, 2021 5:15pm
